Medical Health & Life Science Research News

Immunohistochemistry market outlook to 2021 explored in latest research

Immunohistochemistry market outlook to 2021 explored in latest research

Factors such as the growing prevalence of cancer and rapidly increasing geriatric population across the globe are the primary driving the growth of this market.

- Agency -.

Inquire Report @ goo.gl/1ZR775

The immunohistochemistry (IHC) market is projected to reach USD 2.12 Billion by 2021, growing at a CAGR of 7.3% during the forecast period of 2016 to 2021. 

Other factors driving the IHC market growth include increasing healthcare spending and improving healthcare infrastructure resulting in an increasing number of hospitals and diagnostic laboratories. Several manufacturers in the immunohistochemistry market are relied majorly on launching the new products in order to achieve growth in the immunohistochemistry market.

- Agency -.

In addition, market players are focusing on acquiring local market players to expand their portfolios and enhance their distribution channels in emerging markets.

The global immunohistochemistry market is segmented based on product, application, end user, and region. Based on product, the immunohistochemistry market is segmented into antibodies, reagents, equipment, and kits.

Based on application, the immunohistochemistry market is segmented into diagnostics and drug testing. The diagnostic segment is further divided into cancer, infectious diseases, cardiovascular diseases, autoimmune diseases, diabetes, and nephrological diseases.

On the basis of end user, the market is segmented into hospitals & diagnostic laboratories, research institutions, and other end users. This report also provides market information across major regional segments, namely, North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

Access This Report @ goo.gl/eOdtJW

North America is the largest market for immunohistochemistry, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. However, Asia-Pacific possesses lucrative growth potential for the immunohistochemistry market during the forecast period.

The economic growth of APAC countries, rising number of chronic diseases, rising standard of living, growing demand for quality medical care, increasing healthcare spending and government initiatives, and rising awareness on the use of immunohistochemistry tests are expected to drive market growth of the Asia-Pacific region during the forecast period.

Key Points From Table Of Content:

5 Market Overview

5.1 Introduction
5.2 Key Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Growing Prevalence of Cancer
5.2.1.2 Rapidly Increasing Geriatric Population
5.2.1.3 Rapid Technological Developments in the Ivd Industry
5.2.1.4 Increasing Healthcare Spending
5.2.2 Market Restraints
5.2.2.1 Limited Reimbursements
5.2.2.2 Implementation of Excise Duty By the U.S. Government
5.2.3 Market Opportunities
5.2.3.1 Rapid Growth in the Emerging Markets of APAC and Latin America
5.2.3.2 Increasing Demand for Personalized Medicine
5.2.4 Market Challenge
5.2.4.1 Regulatory Restrictions

Download sample copy @ goo.gl/SOsujX

12 Company Profiles

(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

12.1 Introduction
12.2 F. Hoffmann-LA Roche AG
12.3 Danaher Corporation
12.4 Agilent Technologies, Inc.
12.5 Thermo Fisher Scientific Inc.
12.6 Merck Millipore
12.7 Bio-Rad Laboratories, Inc.
12.8 Perkinelmer, Inc.
12.9 Abcam PLC
12.10 Cell Signaling Technology, Inc.
12.11 Bio SB

News From

RnR Market Research - Market Research and Competitive Analysis ReportsRnR Market Research
Category: Market Research Publishers and RetailersCompany profile: RnRMarketResearch.com is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.